Clinical Trials
194
Participants
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-04-20
Completion:
2029-02-01
Conditions
Oligometastatic Prostate Carcinoma
Prostate Adenocarcinoma
Prostate Ductal Adenocarcinoma
Prostate Intraductal Carcinoma
Stage IVB Prostate Cancer AJCC v8
Interventions
PROCEDURE
OTHER
DRUG
RADIATION
No Results Yet
1714
Participants
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-02-01
Completion:
2026-02-09
Conditions
Advanced Head and Neck Squamous Cell Carcinoma
Advanced Hypopharyngeal Squamous Cell Carcinoma
Advanced Laryngeal Squamous Cell Carcinoma
Advanced Oropharyngeal Squamous Cell Carcinoma
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
DRUG
PROCEDURE
OTHER
RADIATION
No Results Yet
166
Participants
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-09-22
Completion:
2025-03-31
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
2050
Participants
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-12-06
Completion:
2026-11-11
Conditions
Prostate Adenocarcinoma
Interventions
DRUG
RADIATION
No Results Yet
1314
Participants
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2021-08-25
Completion:
2027-08-01
Conditions
Arthritis, Psoriatic
Interventions
DRUG
No Results Yet
70
Participants
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-18
Completion:
2022-06-26
Conditions
Hypertension in Pregnancy
Postpartum Preeclampsia
Interventions
DRUG
50
Participants
Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-05-19
Completion:
2024-10-25
Conditions
COPD
Interventions
BEHAVIORAL
OTHER
40
Participants
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-05-12
Completion:
2027-08-31
Conditions
Lupus Nephritis
Interventions
DRUG
No Results Yet
20
Participants
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-06-23
Completion:
2026-09-21
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Prediabetes
Interventions
OTHER
DIETARY_SUPPLEMENT
No Results Yet
37
Participants
Metformin and Nightly Fasting in Women With Early Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2023-04-04
Completion:
2025-12-16
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Breast Ductal Carcinoma In Situ
Invasive Breast Carcinoma
Interventions
PROCEDURE
DRUG
OTHER
No Results Yet
15
Participants
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-09-28
Completion:
2037-10-30
Conditions
Prostatic Neoplasms
Interventions
DRUG
No Results Yet
18
Participants
TriPRIL CAR T Cells in Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-05
Completion:
2026-01-01
Conditions
Multiple Myeloma
Multiple Myeloma in Relapse
Refractory Multiple Myeloma
Interventions
DRUG
No Results Yet
40
Participants
Cannabidiol (CBD) in Adults With ASD
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2023-04-20
Completion:
2026-12-31
Conditions
Autism Spectrum Disorder
Interventions
DRUG
No Results Yet
297
Participants
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-04-15
Completion:
2025-10-28
Conditions
Depression
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Interventions
OTHER
No Results Yet
100
Participants
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2020-01-09
Completion:
2026-10-31
Conditions
Central Nervous System Lymphoma
Hematopoietic and Lymphoid Cell Neoplasm
Leukemia
Lymphoma
Plasma Cell Myeloma
Secondary Central Nervous System Lymphoma
Interventions
PROCEDURE
OTHER
No Results Yet
614
Participants
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-09-13
Completion:
2026-11-30
Conditions
B-cell Malignancy
Marginal Zone Lymphoma
Follicular Lymphoma
Non-Hodgkin Lymphoma
Waldenström Macroglobulinemia
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Mantle Cell Lymphoma
Diffuse Large B Cell Lymphoma
Interventions
DRUG
No Results Yet
38
Participants
Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-04-05
Completion:
2025-12-31
Conditions
Acute Myeloid Leukemia, Adult
Interventions
DRUG
No Results Yet
77
Participants
Alcohol and Cannabis Co-Use and the Gut-Brain Axis
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2022-02-25
Completion:
2024-12-23
Conditions
Cannabis Use
Alcohol Use
Inflammation
No Results Yet
60
Participants
Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-07-16
Completion:
2025-10-03
Conditions
Parkinson Disease
Interventions
BIOLOGICAL
OTHER
No Results Yet
140
Participants
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-01-04
Completion:
2026-04-30
Conditions
Liver and Intrahepatic Bile Duct Neoplasm
Metastatic Malignant Neoplasm in the Liver
Primary Malignant Liver Neoplasm
Interventions
OTHER
PROCEDURE
No Results Yet
224
Participants
Gender/Sex & CUD Remission
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-11-15
Completion:
2025-10-27
Conditions
Cannabis Use Disorder, Mild
Cannabis Use Disorder, Moderate
Cannabis Use Disorder, Severe
Interventions
BEHAVIORAL
No Results Yet
16372
Participants
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-07-01
Completion:
2023-05-25
Conditions
SARS-CoV-2 Infection
COVID-19
Interventions
BIOLOGICAL
OTHER
25
Participants
A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-01-13
Completion:
2025-04-23
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia
Interventions
BIOLOGICAL
DRUG
No Results Yet
900
Participants
Video Images About Decisions for Ethical Outcomes in the Emergency Department (VIDEO-ED)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-04-25
Completion:
2025-06-10
Conditions
Emergencies
Interventions
BEHAVIORAL
No Results Yet
405
Participants
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-08-30
Completion:
2026-08-04
Conditions
Arthritis, Psoriatic
Interventions
DRUG
No Results Yet
427
Participants
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-10-07
Completion:
2027-12-31
Conditions
Lung Adenocarcinoma
Lung Adenosquamous Carcinoma
Lung Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IIIC Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Interventions
PROCEDURE
BIOLOGICAL
OTHER
RADIATION
No Results Yet
24
Participants
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-07-23
Completion:
2026-06-30
Conditions
Pancreatic Adenocarcinoma
Interventions
DRUG
No Results Yet
743
Participants
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-08-19
Completion:
2029-02-14
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
8
Participants
Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-06-11
Completion:
2024-12-31
Conditions
Metastatic Esophageal Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Interventions
DRUG
No Results Yet
163
Participants
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-07-07
Completion:
2025-01-31
Conditions
Urinary Bladder Neoplasms
Interventions
DRUG
BIOLOGICAL
No Results Yet
18
Participants
All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-18
Completion:
2026-01-15
Conditions
Metastatic Lung Non-Small Cell Carcinoma
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8
Interventions
BIOLOGICAL
DRUG
No Results Yet
5
Participants
A Study of Yutiq Steroid Insert During Glaucoma Tube Implant Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-07-20
Completion:
2027-06-30
Conditions
Glaucoma
Interventions
DRUG
No Results Yet
658
Participants
A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-05-27
Completion:
2026-07-28
Conditions
Hidradenitis Suppurativa
Interventions
DRUG
No Results Yet
17935
Participants
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-06-30
Completion:
2025-08-27
Conditions
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Interventions
BIOLOGICAL
OTHER
No Results Yet
75
Participants
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-03-28
Completion:
2026-11-30
Conditions
Chronic Lymphocytic Leukemia (CLL)
Interventions
DRUG
No Results Yet
500
Participants
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-01-04
Completion:
2026-06-30
Conditions
Locally Advanced Head and Neck Squamous Cell Carcinoma
Aged
Interventions
DRUG
RADIATION
No Results Yet
80
Participants
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2026-01-15
Completion:
2028-02-28
Conditions
Lupus Nephritis
Interventions
OTHER
DRUG
No Results Yet
1054
Participants
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-06-17
Completion:
2024-12-30
Conditions
Arthritis, Psoriatic
Interventions
DRUG
No Results Yet
2210
Participants
Implementing Inclusive Fraction Intervention Classwide
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-09-24
Completion:
2026-08-31
Conditions
Math Learning Difficulty
Interventions
BEHAVIORAL
No Results Yet
102
Participants
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-07-21
Completion:
2032-12-30
Conditions
Renal Allograft Recipients
Interventions
BIOLOGICAL
DRUG
No Results Yet
Showing 40 trials per page · Total 557382 trials